Loading insider details...
Beta
Latest Form 4 (Jun 17, 2026): Exercise/Conversion of 6,030 TRAX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 17, 2026 | First Tracks Biotherapeutics, Inc. (TRAX) | Exercise/Conversion | 6,030 | n/a |
| Jun 15, 2026 | Arcturus Therapeutics Holdings Inc. (ARCT) | Grant/Award | 15,000 | n/a |
| May 29, 2026 | Immix Biopharma, Inc. (IMMX) | Grant/Award | 6,250 | n/a |
| May 14, 2026 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/Award | 15,000 | n/a |
| Apr 22, 2026 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/Award | 784 | n/a |
| Jan 16, 2026 | ANAPTYSBIO, INC (ANAB) | Exercise/Conversion | 11,000 | $287.2K |
| Jan 8, 2026 | ANAPTYSBIO, INC (ANAB) | Grant/Award | 5,500 | n/a |
| Jun 23, 2025 | Immix Biopharma, Inc. (IMMX) | Grant/Award | 33,000 | n/a |
| Jun 17, 2025 | ANAPTYSBIO, INC (ANAB) | Exercise/Conversion | 6,030 | n/a |
| Jun 12, 2025 | Arcturus Therapeutics Holdings Inc. (ARCT) | Grant/Award | 15,000 | n/a |